Lung cancer survivorship research at the National Institutes of Health funded during Fiscal Years 2017–2024

Introduction There is a growing number of lung cancer survivors living longer with complex, ongoing needs. This paper describes NIH-funded survivorship research with lung cancer survivor populations.Methods Research grants focused on survivorship for people with lung cancer that were newly funded during Fiscal Years 2017–2024 were identified using a text mining algorithm from the NIH Research, Condition, and Disease Categorization (RCDC) system with survivorship-relevant terms. Included grants were double coded to extract study characteristics, population, and specific study focus.Results A total of 33 grants were included in this portfolio review, representing 3.8% of the overall survivorship portfolio. Survivorship research areas included care delivery (30.3%), late- or long-term effects (27.3%), and acute psychosocial or physiological toxicities (24.2%). None of the grants focused on financial impact. Specific populations of lung cancer survivors included people living with advanced lung cancer (18.2%), older adults (15.2%), and racial and ethnic minority survivors (15.2%).Conclusions There is a further need to study lung cancer survivors living in rural areas, long-term survivors, survivors from sexual and gender minority populations, and lung cancer caregivers. Research focused on improving health equity for lung cancer survivors who experience disparities is also critical to ensure improved health outcomes.